EUCTR2011-001824-39-GB进行中（未招募）1 期
A randomized, double-blind, double-dummy, placebo-controlled, 3-period crossover study to evaluate the pharmacodynamics, pharmacokinetics, safety and tolerability of orally inhaled indacaterol administered viathe EPIC test fixture and the Concept1 device in adult patients with persistent asthma.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Male and female patients with asthma, aged 18 or above
- •- Patients using inhaled corticosteroid (with or without long acting beta agonist)
- •- Patients who demonstrate an increase in FEV1 after inhaling a short acting beta agonist
- •- Other protocol-defined inclusion criteria apply.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 39
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 3
排除标准
- •- Asthma exacerbations in previous 6 months COPD or other pulmonary disease
- •- Excessive use of short acting beta agonists
- •Other protocol-defined exclusion criteria apply.
研究者
相似试验
已完成
不适用
A randomized, double-blind, double-dummy, placebo-controlled, single dose, 4-way cross-over study of the reversibility of cognitive deficits induced by a nicotinic anti-cholinergic challenge with mecamylamine by a cholinesterase inhibitor and a nicotinic receptor agonistAlheimer's disease10057167NL-OMON42052Centre for Human Drug Research28
招募中
4 期
A clinical trial to understand changes in exhaled breath and lung function tests with different doses of inhaled steroid (Beclomethasone dipropionate) in moderate to severe asthma patients.CTRI/2018/02/011953Chest Research Foundation
已完成
3 期
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease(COPD) ICTRI/2009/091/000141Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd860
已完成
不适用
A randomized, double-blind, double-dummy, placebo-controlled, 3-way crossover proof of concept study of intradermally administered desmopressin in healthy volunteers using a nanoporous microneedle array.NL-OMON48081MyLife Technologies6
已完成
3 期
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease(COPD) IICTRI/2009/091/000147Boehringer Ingelheim Pharmaceuticals860